WO2008093060A3 - Peptides et leur utilisation - Google Patents
Peptides et leur utilisation Download PDFInfo
- Publication number
- WO2008093060A3 WO2008093060A3 PCT/GB2008/000283 GB2008000283W WO2008093060A3 WO 2008093060 A3 WO2008093060 A3 WO 2008093060A3 GB 2008000283 W GB2008000283 W GB 2008000283W WO 2008093060 A3 WO2008093060 A3 WO 2008093060A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptides
- sequence
- amino acids
- same
- antifungal agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08701955A EP2114988A2 (fr) | 2007-02-02 | 2008-01-28 | Peptides et leur utilisation |
CA2706744A CA2706744C (fr) | 2007-02-02 | 2008-01-28 | Peptides antifongiques et leur utilisation |
US12/525,523 US9169290B2 (en) | 2007-02-02 | 2008-01-28 | Peptides and their use |
AU2008211789A AU2008211789B2 (en) | 2007-02-02 | 2008-01-28 | Peptides and their use |
JP2009547750A JP2010517988A (ja) | 2007-02-02 | 2008-01-28 | ペプチドおよびその使用 |
NZ578970A NZ578970A (en) | 2007-02-02 | 2008-01-28 | Antimicrobial peptides comprising one basic amino acid |
CN200880009167.7A CN101679487B (zh) | 2007-02-02 | 2008-01-28 | 肽及其用途 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89928307P | 2007-02-02 | 2007-02-02 | |
GB0702020.9 | 2007-02-02 | ||
US60/899,283 | 2007-02-02 | ||
GBGB0702020.9A GB0702020D0 (en) | 2007-02-02 | 2007-02-02 | Peptides and their use |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008093060A2 WO2008093060A2 (fr) | 2008-08-07 |
WO2008093060A3 true WO2008093060A3 (fr) | 2008-10-23 |
Family
ID=37891189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2008/000283 WO2008093060A2 (fr) | 2007-02-02 | 2008-01-28 | Peptides et leur utilisation |
Country Status (17)
Country | Link |
---|---|
US (1) | US9169290B2 (fr) |
EP (2) | EP2251348B1 (fr) |
JP (2) | JP2010517988A (fr) |
CN (1) | CN101679487B (fr) |
AU (1) | AU2008211789B2 (fr) |
CA (1) | CA2706744C (fr) |
CY (1) | CY1115140T1 (fr) |
DK (1) | DK2251348T3 (fr) |
ES (1) | ES2449615T3 (fr) |
GB (1) | GB0702020D0 (fr) |
HK (1) | HK1145506A1 (fr) |
HR (1) | HRP20140185T1 (fr) |
NZ (1) | NZ578970A (fr) |
PL (1) | PL2251348T3 (fr) |
PT (1) | PT2251348E (fr) |
SI (1) | SI2251348T1 (fr) |
WO (1) | WO2008093060A2 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0702021D0 (en) | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
WO2009153418A1 (fr) * | 2008-06-16 | 2009-12-23 | Centre National De La Recherche Scientifique (C.N.R.S) | Peptides harp inhibant la croissance tumorale |
FR2941231B1 (fr) | 2009-01-16 | 2016-04-01 | Sederma Sa | Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques. |
CN102432672A (zh) * | 2011-12-13 | 2012-05-02 | 重庆理工大学 | 一组新型合成抗菌肽及其应用 |
GB201204457D0 (en) * | 2012-03-14 | 2012-04-25 | Novabiotics Ltd | Polypeptides and their use |
HRP20231151T1 (hr) | 2012-03-19 | 2024-01-05 | Cidara Therapeutics, Inc. | Režimi za doziranje spojeva iz klase ehinokandina |
US20160250285A1 (en) * | 2013-10-30 | 2016-09-01 | University Of Western Australia | Neuroprotective peptides |
GB201405891D0 (en) * | 2014-04-02 | 2014-05-14 | Novabiotics Ltd | Modified antimicrobial peptides |
US10815276B2 (en) | 2014-05-21 | 2020-10-27 | Entrada Therapeutics, Inc. | Cell penetrating peptides and methods of making and using thereof |
HUE045872T2 (hu) | 2014-05-21 | 2020-01-28 | Entrada Therapeutics Inc | Sejteket penetráló peptidek és ezek elõállítására és alkalmazására szolgáló eljárások |
EP3185880B1 (fr) | 2014-08-27 | 2020-02-12 | Ohio State Innovation Foundation | Inhibiteurs améliorés de la peptidyl-calcineurine |
WO2017034961A1 (fr) * | 2015-08-21 | 2017-03-02 | Trilogy Therapeutics, Inc. | Procédés de traitement d'une infection pulmonaire avec la caspofungine |
WO2017120471A1 (fr) | 2016-01-08 | 2017-07-13 | Cidara Therapeutics, Inc. | Procédés de prévention et de traitement d'infections à pneumocystis |
WO2017161016A1 (fr) | 2016-03-16 | 2017-09-21 | Cidara Therapeutics, Inc. | Schémas posologiques pour le traitement d'infections fongiques |
GB201609925D0 (en) * | 2016-06-07 | 2016-07-20 | Novabiotics Ltd | Formulation |
WO2018191692A1 (fr) * | 2017-04-14 | 2018-10-18 | Cidara Therapeutics, Inc. | Procédés de traitement d'infections fongiques |
WO2019014333A1 (fr) | 2017-07-12 | 2019-01-17 | Cidara Therapeutics, Inc. | Compositions et méthodes pour le traitement d'infections fongiques |
US11576946B2 (en) | 2018-01-29 | 2023-02-14 | Ohio State Innovation Foundation | Peptidyl inhibitors of calcineurin-NFAT interaction |
TW201945014A (zh) | 2018-02-22 | 2019-12-01 | 美商安卓達治療股份有限公司 | 用於治療粒線體性神經胃腸腦病變之組合物及方法 |
US11344614B2 (en) * | 2018-09-29 | 2022-05-31 | Emergex Vaccines Holding Ltd. | Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes |
KR102429281B1 (ko) * | 2020-05-25 | 2022-08-05 | (주)노바셀테크놀로지 | 신규 안구건조증 치료용 약학적 조성물 |
CN113336824A (zh) * | 2021-04-30 | 2021-09-03 | 重庆理工大学 | 一种多肽在作为pd-1/pd-l1蛋白-蛋白相互作用(ppi)调节剂中的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0149254A2 (fr) * | 1983-12-29 | 1985-07-24 | The Research Foundation Of State University Of New York | Compositions fongicides contenant des polypeptides renfermant de la L-histidine |
WO2004050685A2 (fr) * | 2002-11-29 | 2004-06-17 | Adaptive Therapeutics, Inc. | Agents therapeutiques antifongiques |
US20040229801A1 (en) * | 2003-04-07 | 2004-11-18 | Takumi Kawabe | Anti-fungal compounds and methods of use |
WO2007072037A1 (fr) * | 2005-12-22 | 2007-06-28 | Novabiotics Limited | Peptides cycliques antimicrobiens |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646120A (en) * | 1990-10-24 | 1997-07-08 | Allelix Biopharmaceuticals, Inc. | Peptide-based inhibitors of HIV replication |
BR9809138A (pt) * | 1997-05-21 | 2001-08-28 | Trustees For The Leland Stanfo | Conjugado e método para aumentar o transporte de um composto selecionado atravessando uma membrana biológica |
US8038984B2 (en) * | 1998-06-20 | 2011-10-18 | Washington University | Membrane-permeant peptide complexes for treatment of sepsis |
US7049395B2 (en) * | 2000-05-02 | 2006-05-23 | Yale University | Anti-inflammatory compounds and uses thereof |
US20040142892A1 (en) * | 2001-04-30 | 2004-07-22 | The University Of British Columbia | Autogene nucleic acids encoding a secretable RNA polymerase |
US7033991B2 (en) * | 2001-07-16 | 2006-04-25 | Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College | Inhibiting furin with polybasic peptides |
WO2003020213A2 (fr) * | 2001-08-30 | 2003-03-13 | Praecis Pharmaceuticals Incorporated | Procedes et compositions pour le traitement de troubles inflammatoires |
US20050203892A1 (en) * | 2004-03-02 | 2005-09-15 | Jonathan Wesley | Dynamically integrating disparate systems and providing secure data sharing |
CN101031583B (zh) | 2004-08-18 | 2013-06-05 | 诺瓦生命科学有限公司 | 包含含有精氨酸和/或赖氨酸的基序的抗微生物肽 |
JP4520477B2 (ja) * | 2006-10-31 | 2010-08-04 | 株式会社マルハニチロ食品 | 抗真菌ペプチドまたはそれを含有するペプチド組成物とその製造方法 |
GB0702021D0 (en) | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
GB0702022D0 (en) | 2007-02-02 | 2007-03-14 | Novabiotics Ltd | Peptides and their use |
-
2007
- 2007-02-02 GB GBGB0702020.9A patent/GB0702020D0/en not_active Ceased
-
2008
- 2008-01-28 US US12/525,523 patent/US9169290B2/en active Active
- 2008-01-28 PL PL10009304T patent/PL2251348T3/pl unknown
- 2008-01-28 CN CN200880009167.7A patent/CN101679487B/zh active Active
- 2008-01-28 SI SI200831157T patent/SI2251348T1/sl unknown
- 2008-01-28 DK DK10009304.6T patent/DK2251348T3/en active
- 2008-01-28 PT PT100093046T patent/PT2251348E/pt unknown
- 2008-01-28 CA CA2706744A patent/CA2706744C/fr active Active
- 2008-01-28 EP EP10009304.6A patent/EP2251348B1/fr active Active
- 2008-01-28 AU AU2008211789A patent/AU2008211789B2/en active Active
- 2008-01-28 NZ NZ578970A patent/NZ578970A/en unknown
- 2008-01-28 JP JP2009547750A patent/JP2010517988A/ja active Pending
- 2008-01-28 EP EP08701955A patent/EP2114988A2/fr not_active Withdrawn
- 2008-01-28 WO PCT/GB2008/000283 patent/WO2008093060A2/fr active Application Filing
- 2008-01-28 ES ES10009304.6T patent/ES2449615T3/es active Active
-
2010
- 2010-12-22 HK HK10112002.9A patent/HK1145506A1/xx unknown
-
2013
- 2013-07-04 JP JP2013141102A patent/JP5882260B2/ja not_active Expired - Fee Related
-
2014
- 2014-02-28 HR HRP20140185AT patent/HRP20140185T1/hr unknown
- 2014-02-28 CY CY20141100165T patent/CY1115140T1/el unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0149254A2 (fr) * | 1983-12-29 | 1985-07-24 | The Research Foundation Of State University Of New York | Compositions fongicides contenant des polypeptides renfermant de la L-histidine |
WO2004050685A2 (fr) * | 2002-11-29 | 2004-06-17 | Adaptive Therapeutics, Inc. | Agents therapeutiques antifongiques |
US20040229801A1 (en) * | 2003-04-07 | 2004-11-18 | Takumi Kawabe | Anti-fungal compounds and methods of use |
WO2007072037A1 (fr) * | 2005-12-22 | 2007-06-28 | Novabiotics Limited | Peptides cycliques antimicrobiens |
Non-Patent Citations (5)
Title |
---|
HONG S Y ET AL: "The effect of charge increased on the specifity and activity of a short antimicrobial peptide", PEPTIDES, ELSEVIER, AMSTERDAM, vol. 22, no. 10, 1 January 2001 (2001-01-01), pages 1669 - 1674, XP002989856, ISSN: 0196-9781 * |
LEHRER RI ET AL.: "Modulation of the In Vitro Candidacial Activity of Human Neutrophil Defensins by Target Cell Metabolism and Divalent Cations", JOURNAL OF CLINICAL INVESTIGATION, vol. 81, June 1988 (1988-06-01), pages 1829 - 1835, XP002482896 * |
PARK Y ET AL: "A Leu-Lys-rich antimicrobial peptide: activity and mechanism", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - PROTEINS & PROTEOMICS, ELSEVIER, vol. 1645, no. 2, 21 February 2003 (2003-02-21), pages 172 - 182, XP004405445, ISSN: 1570-9639 * |
POLLOCK JJ ET AL.: "Fungistatic and Fungicidal Activity of Human Parotid Salivary Histidine-Rich Polypeptides on Candida albicans", INFECTION AND IMMUNITY, vol. 44, no. 3, June 1984 (1984-06-01), pages 702 - 707, XP002482895 * |
ZHU J ET AL.: "Synthetic Histidine-Rich Peptides Inhibit Candida Species and Other Fungi In Vitro: Role of Endocytosis and Treatment Implications", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 50, no. 8, August 2006 (2006-08-01), pages 2797 - 2805, XP002482897 * |
Also Published As
Publication number | Publication date |
---|---|
GB0702020D0 (en) | 2007-03-14 |
EP2251348A2 (fr) | 2010-11-17 |
DK2251348T3 (en) | 2014-03-03 |
CN101679487A (zh) | 2010-03-24 |
PL2251348T3 (pl) | 2014-05-30 |
CN101679487B (zh) | 2018-04-03 |
SI2251348T1 (sl) | 2014-05-30 |
EP2114988A2 (fr) | 2009-11-11 |
HRP20140185T1 (hr) | 2014-05-09 |
US9169290B2 (en) | 2015-10-27 |
AU2008211789A1 (en) | 2008-08-07 |
CY1115140T1 (el) | 2016-12-14 |
ES2449615T3 (es) | 2014-03-20 |
JP2014012667A (ja) | 2014-01-23 |
NZ578970A (en) | 2012-04-27 |
US20100184696A1 (en) | 2010-07-22 |
HK1145506A1 (en) | 2011-04-21 |
PT2251348E (pt) | 2014-03-06 |
EP2251348A3 (fr) | 2011-03-02 |
JP2010517988A (ja) | 2010-05-27 |
CA2706744A1 (fr) | 2008-08-07 |
WO2008093060A2 (fr) | 2008-08-07 |
CA2706744C (fr) | 2017-12-05 |
EP2251348B1 (fr) | 2014-01-15 |
JP5882260B2 (ja) | 2016-03-09 |
AU2008211789B2 (en) | 2013-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008093060A3 (fr) | Peptides et leur utilisation | |
WO2008093058A3 (fr) | Peptides et leur utilisation | |
HK1221252A1 (zh) | 限制的 肽及含有其的藥物組合物 | |
IL197923A (en) | Synthetic peptides, pharmaceutical preparations containing them and their uses | |
IL197924A (en) | Synthetic peptides, pharmaceutical preparations containing them and their uses | |
HK1127877A1 (en) | Composition containing peptide as the active ingredient | |
WO2007060117A3 (fr) | Proteines effectrices chimeres se liant a la keratine | |
EP2015849B8 (fr) | Nouvelles compositions cosmétiques contenant au moins un peptide doté d'au moins un cycle aromatique immobilisé | |
EG26619A (en) | PEG-quadrangle arbor polymer for binding to proteins and peptides | |
IL204607A (en) | Anti-protein 15 siglec antagonists - osteoclast-related preparations containing them and their uses | |
IL209386A0 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
ZA200709239B (en) | Compositions for administering RNAIII-inhibiting peptides | |
ZA201003681B (en) | Compositions and methods comprising basic amino acid peptides and proteases | |
EP1951890A4 (fr) | Procedes et compositions comprenant des acides amines non naturels | |
DE602005008996D1 (de) | Radiofluorierte peptide | |
PL1838341T3 (pl) | Kompozycja szczepionki obejmująca białko wiążące fibronektynę lub peptyd wiążący fibronektynę | |
DE602006018856D1 (de) | Neue nutrazeutika-zusammensetzungen | |
EP2066689A4 (fr) | Peptides hyd1 en tant qu'agents anticancereux | |
EP2217702A4 (fr) | Evolution dirigée à l'aide de protéines comportant des acides aminés non naturels | |
SI2234979T1 (sl) | 5-((3,3,3-trifluoro-2-hidroksi-1-arilpropil)amino)-1H-kinolin-2-oni, postopek njihove proizvodnje in njihova uporaba kot protivnetna sredstva | |
WO2008101693A3 (fr) | Applications cosmétiques et pharmaceutiques d'acides aminés n-acylés, et composés structurellement apparentés | |
IL213286A0 (en) | Methods and uses involving heme binding protein 1 | |
IL209304A0 (en) | Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition | |
ZA200805195B (en) | Bacteriocin inducer peptides | |
IL213026A0 (en) | TNA-a INHIBITING PEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880009167.7 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08701955 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2009547750 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 578970 Country of ref document: NZ Ref document number: 2008211789 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008701955 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3036/KOLNP/2009 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2008211789 Country of ref document: AU Date of ref document: 20080128 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12525523 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2706744 Country of ref document: CA |